本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.8659
+0.03494.20%
成交量:76.20万
成交额:65.04万
市值:565.37万
市盈率:-0.07
高:0.8962
开:0.8611
低:0.8223
收:0.8310
数据加载中...
2022/12/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report